Allarity Therapeutics amends registration rights provision in securities purchase agreement with 3i, LP

Allarity Therapeutics, Inc.

Amendment to Securities Purchase Agreement dated Jan 18, 2024, for up to $1.54M in senior convertible notes.
Demand registration rights clarified: Purchaser can request registration starting 90 days after First Closing Date.
Company must file registration statement within 15 days of request and use best efforts to make effective within 45 days.
No other changes; original agreement remains in full force.

item 1.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Allarity Therapeutics, Inc. amended Amendment with 3i, LP (effective 2024-01-25).

Action: amendment
Agreement: equity purchase
Counterparty: 3i, LP
Effective: 2024-01-25

Exact text from the filing

On January 25, 2024, Allarity Therapeutics, Inc., a Delaware corporation (“we,” “our,” or the “Company”) and 3i, LP, a Delaware limited partnership (the “Purchaser”), executed an amendment (the “Amendment”) to that certain Securities Purchase Agreement dated as of January 18, 2024 (the “Original Agreement”).

View on SEC.gov

272 material agreements filed in the last 30 days. Browse all material agreements →

Allarity Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-006554

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.